Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06)
Sign Up to like & getrecommendations! Published in 2017 at "Gastric Cancer"
DOI: 10.1007/s10120-017-0766-x
Abstract: BackgroundS-1 plus cisplatin is a standard regimen for advanced gastric cancer (AGC) in Asia. The ToGA trial established a fluoropyrimidine plus cisplatin and trastuzumab as a standard treatment for human epidermal growth factor receptor 2… read more here.
Keywords: patients her2; her2 positive; gastric cancer; elderly patients ... See more keywords